Similar companies
Galectin Therapeutics X Follower Count
Galectin Therapeutics has 732 followers on X (formerly Twitter), roughly flat (+0.1%) over the past three months.
With 732 followers, Galectin Therapeutics has a smaller X following than industry peers like Amgen (118,612) and Gilead Sciences (72,272).
How Galectin Therapeutics’s X Growth Feeds the GALT AI Score
X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Galectin Therapeutics’s X following into the GALT AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.
For Galectin Therapeutics’s reach on other platforms, see Galectin Therapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.
For real-time conversation volume, see GALT X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.
Month over Month
| Sep 2026 | 731 | |
| Aug 2026 | 729 | |
| Jul 2026 | 730 | |
| Jun 2026 | 730 | |
| May 2026 | 733 |
Galectin Therapeutics X (Twitter) Followers: Frequently Asked Questions
Galectin Therapeutics has 732 followers (732) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.
Galectin Therapeutics's X following has been roughly flat (+0.1%) over the past three months. View the trend chart above for the full history.
X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Galectin Therapeutics's following can reflect shifting public interest. That is why AltIndex combines Galectin Therapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Galectin Therapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.
With fewer than 1,000 followers, Galectin Therapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.
Sign up and get more insights on Galectin Therapeutics.
See Galectin Therapeutics’s complete x followers history
Sign up to unlock 1-year and all-time charts for GALT, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
